News
-
Melodrama 10-Piece Brush Set by DB
Wednesday | Mar 20 2019NEW from Designer Brands (DB) is the exciting Melodrama 10-Piece Brush Set.
-
Chemists’ Own Saline Nasal Spray
Wednesday | Mar 20 2019CHEMISTS' Own has launched the latest addition to its range, Saline Nasal Spray.
-
TGA Brexit contingencies
Tuesday | Mar 19 2019THE Therapeutic Goods Administration (TGA) has announced details of transitional arrangements in the event of a "no deal" exit of the United Kingdom from the European Union.
-
MedAdvisor woos investors
Tuesday | Mar 19 2019LISTED digital medicines management company MedAdvisor put considerable effort yesterday into presenting to potential and current investors its track record and future ambitions.
-
FDA head resigns
Tuesday | Mar 19 2019SCOTT Gottlieb, (pictured) has announced his resignation from the role of commissioner of the US Food and Drug Administration (FDA) after almost two years in the role.
-
UK discount probe
Tuesday | Mar 19 2019BRITAIN'S Competition and Markets Authority has issued a warning to drugmakers about using "anticompetitive discount schemes," but found there were no grounds for action following a probe of discounts offfered by MSD for its Remicade (infliximab).
-
Bigger cancer risk
Tuesday | Mar 19 2019THE Therapeutic Goods Administration (TGA) has warned that Make Coarser Make Bigger capsules, which some people may have bought online, contain the undeclared substances 2-mercaptobenzothiazole (a known carcinogen used in industrial applications), diclofenac (and NSAID) and glibenclamide (a sulfonylurea used for diabetes).
-
“Telestroke” promise
Tuesday | Mar 19 2019THE Labor Party has committed to funding an $11.9 million National Telestroke Network if it takes power at the upcoming election.
-
Nifedipine high dose
Tuesday | Mar 19 2019COMMONLY used cardiac drug nifedipine (Adalat and others), when used in high dose, was associated with more than double the risk of a cardiac arrest than any dose of amlodipine, Dutch and Danish researchers reported at the European Heart Rhythm Association Congress 2019.
-
Alcon acquisition
Tuesday | Mar 19 2019NOVARTIS' eye care division Alcon has announced the acquisition of US-based PowerVision Inc, a privately-held firm focused on creating "fluid-based intraocular lens implants".
